Association between management of metabolic syndrome and progression of early-stage chronic kidney disease: an observational cohort study

References

• Barylski M, Małyszko J, Rysz J, Myśliwiec M, Banach M. Lipids, blood pressure, kidney—What was new in 2011? Arc Med Sci. 2011;7:1055–1066
   PubMed Web of Science ®Google Scholar
• Curhan GC. Prediabetes, prehypertension—Is it time for pre-CKD? Clin J Am Soc Nephrol. 2010;5:557–559
   PubMedGoogle Scholar
• Reaven GM. Insulin resistance and human disease: A short history. J Basic Clin Physiol Pharmacol. 1998;9:387–406
   PubMedGoogle Scholar
• Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev. 1998;20:157–172
   PubMedGoogle Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
   PubMed Web of Science ®Google Scholar
• Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–374
   PubMed Web of Science ®Google Scholar
• Ritz E. Metabolic syndrome and kidney disease. Blood Purif. 2008;26:59–62
   PubMedGoogle Scholar
• Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008;31:2357–2361
   PubMed Web of Science ®Google Scholar
• Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105:626–635
   PubMed Web of Science ®Google Scholar
• Nestel P, Lyu R, Low LP, et al. Metabolic syndrome: Recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr. 2007;16:362–367
   PubMed Web of Science ®Google Scholar
• NCEP, Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP). JAMA. 2001;285:2486–2497
   PubMedGoogle Scholar
• Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: Insights from therapeutic interventions. J Am Coll Cardiol. 2005;46:1978–1985
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs 2007;30:987–992
   PubMed Web of Science ®Google Scholar
• Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK. Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am J Kidney Dis. 2009;53:751–759
   PubMed Web of Science ®Google Scholar
• Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among non-diabetic adults. J Am Soc Nephrol. 2005;16:2134–2140
   PubMed Web of Science ®Google Scholar
• Lee CC, Sun CY, Wu IW, Wang SY, Wu MS. Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression-a paradoxical phenomenon. Clin Nephrol. 2011;75:141–149
   PubMed Web of Science ®Google Scholar
• Health Promotion Administration, Ministry of Health and Welfare, Republic of China (Taiwan). Definition of metabolic syndrome 2007 edition. 2007. Available at: http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?No=200712250123&parentid=200712250023. Accessed September 20, 2014
   Google Scholar
• Duran-Perez EG, Almeda-Valdes P, Cuevas-Ramos D, Campos-Barrera E, Muñoz-Hernandez L, Gomez-Perez FJ. Treatment of metabolic syndrome slows progression of diabetic nephropathy. Metab Syndr Relat Disord. 2011;9:483–489
   PubMed Web of Science ®Google Scholar
• Tomaszewski M, Charchar F, Maric C, et al. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int. 2007;71:816–821
   PubMed Web of Science ®Google Scholar
• Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis. 2010;20:72–77
   PubMed Web of Science ®Google Scholar
• Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res. 2007;30:937–943
   PubMed Web of Science ®Google Scholar
• Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab. 2012;97:1268–1276
   PubMed Web of Science ®Google Scholar
• Ryu S, Chang Y, Woo HY, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis. 2009;53:59–69
   PubMedGoogle Scholar
• Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: Time for a course correction. J Am Soc Nephrol. 2008;19:844–846
   PubMed Web of Science ®Google Scholar
• Clark WF, Macnab JJ, Sontrop JM, et al. Dipstick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol. 2011;22:1729–1736
   PubMedGoogle Scholar
• Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–591
   PubMed Web of Science ®Google Scholar
• Hwang IC, Kim KK, Jee SH, Kang HC. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria. Yonsei Med J. 2011;52:220–226
   PubMedGoogle Scholar
• Sun F, Tao Q, Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118924 non-diabetic Taiwanese in a retrospective cohort. Nephrology (Carlton). 2010;15:84–92
   PubMedGoogle Scholar
• Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646–661
   PubMed Web of Science ®Google Scholar